Host Susceptibility Factors to Bacterial Infections in Type 2 Diabetes
Tóm tắt
Từ khóa
Tài liệu tham khảo
KE Dooley, 2009, Tuberculosis and diabetes mellitus: convergence of two epidemics, Lancet Infect Dis, 9, 737, 10.1016/S1473-3099(09)70282-8
MS Bader, 2008, Diabetic foot infection, Am Fam Physician, 78, 71
H Yano, 2002, Insulin treatment directly restores neutrophil phagocytosis and bactericidal activity in diabetic mice and thereby improves surgical site <italic>Staphylococcus aureus</italic> infection, Infect Immun, 80, 4409, 10.1128/IAI.00787-12
F Hanses, 2011, Reduced neutrophil apoptosis in diabetic mice during <italic>Staphylococcal</italic> infection leads to prolonged Tnfα production and reduced neutrophil clearance, PLoS ONE, 6, e23633, 10.1371/journal.pone.0023633
JD Breen, 1995, <italic>Staphylococcus aureus</italic> infections in diabetic patients, Infect Dis Clin North Am, 9, 11, 10.1016/S0891-5520(20)30638-3
G Jacobsson, 2007, The epidemiology of and risk factors for invasive <italic>Staphylococcus aureus</italic> infections in western Sweden, Scand J Infect Dis, 39, 6, 10.1080/00365540600810026
TH Skoff, 2009, Increasing burden of invasive group B streptococcal disease in non-pregnant adults, 1990–2007, Clin Infect Dis, 49, 85, 10.1086/599369
YT Lin, 2013, <italic>Klebsiella pneumoniae</italic> liver abscess in diabetic patients: association of glycemic control with the clinical characteristics, BMC Infect Dis, 13, 56, 10.1186/1471-2334-13-56
SE Geerlings, 2008, Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment, Int J Antimicrob Agents, 31, 554, 10.1016/j.ijantimicag.2007.07.042
CC Leung, 2008, Diabetic control and risk of tuberculosis: a cohort study, Am J Epidemiol, 167, 1486, 10.1093/aje/kwn075
A Pablos-Mendez, 1997, The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics, Am J Public Health, 87, 574, 10.2105/AJPH.87.4.574
A Leegaard, 2011, Diabetes, glycemic control, and risk of tuberculosis. A population-based case-control study, Diabetes Care, 34, 2530, 10.2337/dc11-0902
AC Cheng, 2005, Melioidosis: epidemiology, pathophysiology, and management, Clin Microbiol Rev, 18, 383, 10.1128/CMR.18.2.383-416.2005
S Chanchamroen, 2009, Human polymorphonuclear neutrophil responses to <italic>Burkholderia pseudomallei</italic> in healthy and diabetic subjects, Infect Immun, 77, 456, 10.1128/IAI.00503-08
D Riyapa, 2012, Neutrophil Extracellular Traps exhibit antibacterial activity against <italic>Burkholderia pseudomallei</italic> and are influenced by bacterial and host factors, Infect Immun, 80, 3921, 10.1128/IAI.00806-12
DI Gomez, 2013, Reduced <italic>Mycobacterium tuberculosis</italic> association with monocytes from diabetes patients that have poor glucose control, Tuberculosis, 93, 192, 10.1016/j.tube.2012.10.003
AY Peleg, 2007, Common infections in diabetes: pathogenesis, management and relationship to glycemic control, Diabetes Metab Res Rev, 23, 3, 10.1002/dmrr.682
EJ Rayfield, 1982, Infection and diabetes: the case for glucose control, Am J Med, 72, 439, 10.1016/0002-9343(82)90511-3
J Rich, 2005, The pathogenesis of <italic>Staphylococcus aureus</italic> infection in the diabetic NOD mouse, Diabetes, 54, 2904, 10.2337/diabetes.54.10.2904
KS Tan, 2012, Glutathione deficiency in Type 2 diabetes impairs cytokine responses and control of intracellular bacteria, J Clin Invest, 122, 2289, 10.1172/JCI57817
ME Stegenga, 2008, Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia, Blood, 112, 82, 10.1182/blood-2007-11-121723
A Berhaus, 1998, AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept, Cardiovasc Res, 37, 586, 10.1016/S0008-6363(97)00233-2
R Ilyas, 2010, High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitus, Immunobiology, 216, 126, 10.1016/j.imbio.2010.06.002
TJ Zwang, 2012, Enhanced iron availability by protein glycation may explain higher infection rates in diabetics, Biometals, 25, 237, 10.1007/s10534-011-9492-8
KS Collison, 2002, RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs), J Leukoc Biol, 71, 433, 10.1189/jlb.71.3.433
MC Wang, 2013, Bacterial characteristics and glycemic control in diabetic patients with <italic>Escherichia coli</italic> urinary tract infection, J Microbiol Immunol Infect, 46, 24, 10.1016/j.jmii.2011.12.024
SE Geerlings, 2002, Adherence of type 1-fimbriated <italic>Escherichia coli</italic> to uroepithelial cells: more in diabetic women than in control subjects, Diabetes Care, 25, 1405, 10.2337/diacare.25.8.1405
SD Knight, 2009, Structure, function and assembly of the type 1 fimbraie, Top Curr Chem, 288, 67, 10.1007/128_2008_13
J Taganna, 2011, Glycosylation changes as important factors for the susceptibility to urinary tract infection, Biochem Soc Trans, 39, 349, 10.1042/BST0390349
JP Garnett, 2013, Metformin reduces airway glucose permeability and hyperglycaemia-induced <italic>Staphylococcus aureus</italic> load independently of effects on blood glucose, Thorax, 68, 835, 10.1136/thoraxjnl-2012-203178
M Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a
GCKW Koh, 2013, Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signalling, PLoS ONE, 8, e54961, 10.1371/journal.pone.0054961